IL139988A0 - Tumor antigen useful in diagnosis and therapy of prostate and colon cancer - Google Patents

Tumor antigen useful in diagnosis and therapy of prostate and colon cancer

Info

Publication number
IL139988A0
IL139988A0 IL13998899A IL13998899A IL139988A0 IL 139988 A0 IL139988 A0 IL 139988A0 IL 13998899 A IL13998899 A IL 13998899A IL 13998899 A IL13998899 A IL 13998899A IL 139988 A0 IL139988 A0 IL 139988A0
Authority
IL
Israel
Prior art keywords
prostate
tmprss2
diagnosis
therapy
colon cancer
Prior art date
Application number
IL13998899A
Other languages
English (en)
Original Assignee
Urogenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urogenesys Inc filed Critical Urogenesys Inc
Publication of IL139988A0 publication Critical patent/IL139988A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL13998899A 1998-06-01 1999-06-01 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer IL139988A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US8759898P 1998-06-01 1998-06-01
US9147498P 1998-06-29 1998-06-29
US12952199P 1999-04-14 1999-04-14
PCT/US1999/012253 WO1999062942A2 (en) 1998-06-01 1999-06-01 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer

Publications (1)

Publication Number Publication Date
IL139988A0 true IL139988A0 (en) 2002-02-10

Family

ID=27375711

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13998899A IL139988A0 (en) 1998-06-01 1999-06-01 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer

Country Status (12)

Country Link
US (1) US20060275304A1 (de)
EP (1) EP1082341B1 (de)
JP (2) JP2002517185A (de)
AT (1) ATE490977T1 (de)
AU (2) AU773187B2 (de)
CA (1) CA2329137C (de)
CY (1) CY1111906T1 (de)
DE (1) DE69943020D1 (de)
DK (1) DK1082341T3 (de)
IL (1) IL139988A0 (de)
PT (1) PT1082341E (de)
WO (1) WO1999062942A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7037667B1 (en) * 1998-06-01 2006-05-02 Agensys, Inc. Tumor antigen useful in diagnosis and therapy of prostate and colon cancer
IL142310A0 (en) * 1998-10-02 2002-03-10 Urogenesys Inc Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
US6902892B1 (en) 1998-10-19 2005-06-07 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
JP2002527758A (ja) * 1998-10-19 2002-08-27 ダイアデクスアス・インコーポレーテッド 前立腺癌を診断、監視、病期分類、イメージング及び治療する方法
AU4484400A (en) * 1999-04-23 2000-11-10 University Of Washington Prostate-specific polynucleotides, polypeptides and their methods of use
ES2317846T3 (es) 1999-08-12 2009-05-01 Agensys, Inc. Antigeno transmembranal de lectina tipo c en el cancer de prostata humano y usos del mismo.
US20020040127A1 (en) * 2000-06-09 2002-04-04 Yuqiu Jiang Compositions and methods for the therapy and diagnosis of colon cancer
ES2305093T3 (es) 2000-06-13 2008-11-01 Bayer Healthcare Ag Regulacion de la serina proteasa transmembrana humana.
WO2002004953A2 (en) * 2000-07-12 2002-01-17 Agensys, Inc. Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
US6743592B1 (en) * 2000-07-25 2004-06-01 The Trustees Of The University Of Pennsylvania Methods, systems and kits for immuno-detection of epitopes expressed on molecules
US20040018973A1 (en) 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
US20070275915A1 (en) * 2003-04-15 2007-11-29 Cell Genesys, Inc. Tmprss2 Regulatory Sequences and Uses Thereof
WO2004097358A2 (en) * 2003-05-02 2004-11-11 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2)
US9957569B2 (en) 2005-09-12 2018-05-01 The Regents Of The University Of Michigan Recurrent gene fusions in prostate cancer
EP2612870A1 (de) 2005-09-12 2013-07-10 The Regents of the University of Michigan Häufige Genfusionen bei Prostatakrebs
EP2140022A2 (de) * 2007-03-30 2010-01-06 Oryzon Genomics, S.A. Nukleinsäureanalyseverfahren
ES2376509T3 (es) 2007-07-06 2012-03-14 The Regents Of The University Of Michigan Reordenamientos de genes mipol 1-etv1.
US8106037B2 (en) 2007-08-03 2012-01-31 The Brigham And Women's Hospital, Inc. Identification and treatment of estrogen responsive prostate tumors
CN102712953A (zh) 2009-09-17 2012-10-03 密歇根大学董事会 前列腺癌中的复发性基因融合物
US8945556B2 (en) 2010-11-19 2015-02-03 The Regents Of The University Of Michigan RAF gene fusions
CN104125852B9 (zh) * 2012-02-15 2017-05-17 弗·哈夫曼-拉罗切有限公司 基于Fc‑受体的亲和色谱
LT3215528T (lt) 2014-11-06 2019-10-25 Hoffmann La Roche Fc srities variantai su modifikuota fcrn jungtimi ir naudojimo būdai

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3040121B2 (ja) * 1988-01-12 2000-05-08 ジェネンテク，インコーポレイテッド 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法
US5288612A (en) * 1991-07-03 1994-02-22 The Scripps Research Institute Assay methods for detecting serum proteases, particularly activated protein C
CA2153254C (en) * 1993-01-15 2002-05-21 Edward R. Lavallie Cloning of enterokinase and method of use
CA2281952C (en) * 1997-02-25 2011-07-19 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
DE69831222T2 (de) * 1997-02-25 2006-07-13 Corixa Corp., Seattle Verbindungen zur immundiagnose von prostatakrebs und deren verwendung
US6800746B2 (en) * 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6657056B2 (en) * 1997-02-25 2003-12-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US20020119531A1 (en) * 1997-02-27 2002-08-29 Olga Bandman Prostate-associated protease antibody
US20030103981A1 (en) * 1997-02-27 2003-06-05 Incyte Genomics, Inc. Methods of use of a prostate-associated protease in the diagnosis and treatment of prostate cancer
US6043033A (en) * 1997-02-27 2000-03-28 Incyte Pharmaceuticals, Inc. Human prostate-associated protease
US6500938B1 (en) * 1998-01-30 2002-12-31 Incyte Genomics, Inc. Composition for the detection of signaling pathway gene expression
AU4839999A (en) * 1998-06-29 2000-01-17 Myriad Genetics, Inc. Tmprss2 is a tumor suppressor
US6291663B1 (en) * 1999-03-03 2001-09-18 Board Of Trustees Of The University Of Arkansas TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
US6331427B1 (en) * 1999-03-26 2001-12-18 Millennium Pharmaceuticals, Inc. Protease homologs
US20020192763A1 (en) * 2000-04-17 2002-12-19 Jiangchun Xu Compositions and methods for the therapy and diagnosis of prostate cancer
US20020160382A1 (en) * 2000-10-11 2002-10-31 Lasek Amy W. Genes expressed in colon cancer
US20030065157A1 (en) * 2001-04-04 2003-04-03 Lasek Amy W. Genes expressed in lung cancer

Also Published As

Publication number Publication date
ATE490977T1 (de) 2010-12-15
CY1111906T1 (el) 2015-11-04
JP2009148265A (ja) 2009-07-09
AU2004202306A1 (en) 2004-06-24
EP1082341B1 (de) 2010-12-08
EP1082341A2 (de) 2001-03-14
AU2004202306C1 (en) 2008-05-01
WO1999062942A3 (en) 2000-06-02
AU4413699A (en) 1999-12-20
AU773187B2 (en) 2004-05-20
PT1082341E (pt) 2011-02-15
AU2004202306B2 (en) 2007-05-24
WO1999062942A2 (en) 1999-12-09
CA2329137A1 (en) 1999-12-09
US20060275304A1 (en) 2006-12-07
DE69943020D1 (de) 2011-01-20
CA2329137C (en) 2011-09-20
DK1082341T3 (da) 2011-03-28
JP2002517185A (ja) 2002-06-18

Similar Documents

Publication Publication Date Title
CY1111906T1 (el) Αντιγονο ογκων χρησιμο για τη διαγνωση και θεραπεια καρκινου του προστατη και του παχεος εντερου
AU1726199A (en) Metastatic cancer regulated gene
DE69734109D1 (de) Humanisierung von anti-carcinoembryonalen Antigen anti-idiotypischen Antikörper und dessen Verwendung als Tumorvakzin und zur Markierung
SG96535A1 (en) Pharmaceutical composition for the treatment or prevention of a malignant tumor
Krüger et al. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87)
NZ516381A (en) Lung tumor proteins in the therapy and diagnosis of lung cancer
HK1022174A1 (en) Antigen binding fragments that specifically detectcancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
BG101077A (en) New peptides
DK0922223T3 (da) Fremgangsmåde til prognosticering af cancer
CY1109254T1 (el) Νεο αντιγονο ογκου χρησιμο στη διαγνωση και θεραπεια καρκινων της ουροδοχου κυστης, των ωοθηκων, του πνευμονα και του νεφρου
AU2818095A (en) Colon specific gene and protein
Ferrone et al. A human high molecular weightmelanoma associated antigen (HMWW_MAA) defined by monoclonal antibodies: a useful marker to radioimage tumor lesions in patients with melanoma. Brookhaven National Laboratories. Associated Universities
Barra et al. Primary structure of human copper-zinc superoxide dismutase. Cysteine-and tryptophan—Containing peptides
WO1998045442A3 (en) Secreted f-spondin homologs
WO1994028129A3 (en) Tumour metastasis gene
NO991653D0 (no) Immunogenisk tumor frigjorte partikler (TLP)-blanding
HK1118861A1 (en) Genes differentially expressed in breast cancer
DE69332583D1 (de) Maspin- ein neues serpin mit tumor unterdrückender aktivität
WO1998042830A3 (en) Noey2 gene compositions and methods of use
AU2002360392A8 (en) New gene expressed in prostate cancer and methods of use
HUP0001270A2 (en) Compositions and methods for the treatment and diagnosis of breast cancer
WO1999043812A3 (en) Dlc-1 gene, a putative tumors suppressor gene
EP1693457A3 (de) In metastasierenden Brust- und Darmkrebs regulierte Gene

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees